Latest stories on MSLE
Satellos stock jumps after FDA clears FSHD trial for forazapadin
Investing.com Markets67 · bullishproduct/pr
Satellos announces U.S. FDA cleared IND application for forazapadin
The Fly63 · neutralproduct/pr
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
TipRanks63 · neutralproduct/pr
Satellos to Present at the 31st Annual Congress of the World Muscle Society
Business Insider55 · neutralproduct/pr
Satellos assigns forazapadin name to SAT-3247
The Fly55 · neutralproduct/pr
Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247
GlobeNewswire63 · neutralproduct/pr
Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247
Business Insider59 · neutralproduct/pr
Satellos to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Satellos to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Satellos initiated with an Outperform at LifeSci Capital
The Fly61 · neutralanalyst
Satellos Bioscience Inc. GAAP EPS of -$0.56
Seeking Alpha28 · bearishearnings
Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress
StockTitan56 · neutralearnings
Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress
GlobeNewswire59 · neutralearnings
Satellos files $300M mixed securities shelf
The Fly24 · bearishgeneral
TRAILHEAD Interim Data: SAT-3247 Shows Consistent Muscle Improvements and Favorable Safety in Adults With DMD
July 8, 2026
MarketChameleon73 · bullishproduct/pr
Satellos Bioscience Shares Climb After FDA Fast Track Designation
Morningstar67 · bullishproduct/pr
Satellos Wins FDA Fast Track Status for Duchenne Drug SAT-3247
TipRanks67 · bullishproduct/pr
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy | MSLE Stock News
StockTitan67 · bullishproduct/pr
Satellos to Present Clinical Program Updates at ICNMD 2026 | MSLE Stock News
StockTitan63 · neutralproduct/pr
Satellos Bioscience Announces Results of Annual Meeting of Shareholders | MSLE Stock News
StockTitan50 · neutralgeneral
Satellos Bioscience to Highlight Neuromuscular Pipeline at June Investor Conferences
TipRanks63 · neutralproduct/pr
Satellos to Participate in Upcoming Investor Conferences | MSLE Stock News
StockTitan55 · neutralgeneral